Global antibiotic resistance in Streptococcus pneumoniae.
about
Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumoniaBuilding a transnational biosurveillance network using semantic web technologies: requirements, design, and preliminary evaluationDecreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community studyAntimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics.Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008Antimicrobial resistance in Canada.High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).Adherence to therapeutic guidelines for patients with community-acquired pneumonia in Australian hospitalsLow-level resistance to rifampin in Streptococcus pneumoniaeEvaluation of the Do Bugs Need Drugs? program in British Columbia: Can we curb antibiotic prescribing?Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in GermanyHeteroresistance to penicillin in Streptococcus pneumoniae.Antimicrobial resistance - Judicious use is the keyResults from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India.In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, contrEfficacy of methylprednisolone in children with severe community acquired pneumonia.Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients.Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strainEfficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.Chemical composition, antioxidant and antibacterial properties of Achillea collina Becker ex Heimerl s.l. and A. pannonica Scheele essential oils.Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes.Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan.Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany
P2860
Q23911823-4CE05287-48C7-49BB-AE49-F4E48D7B6ED6Q28673135-6C0E6A03-2AF0-41C5-94BC-22A41779D3F8Q30980181-BB061E5F-06C4-4C66-84AB-1B97399D3CC0Q31115498-503BFA55-476C-417B-B87C-6475899B3144Q33756049-D6C6193F-6E85-4F0A-BD70-C92CFCEF0DFBQ34133853-C78FCBA6-C8D8-4D26-9BBE-852ABFBCC4BAQ34141387-DB9762A7-FE21-45E4-B4E2-A09140F397D1Q34203870-A2FF6340-ED77-4745-837B-B6BDB742A711Q34734752-48465FA6-8BEA-4C89-9FAF-95D7CCAFAE83Q34789786-25457320-1171-49C5-81AF-2C783688A9D4Q35105368-96335773-69B5-42A8-B90D-C9B6EAAF8E22Q35944300-AE54E8E4-7234-428C-835A-DBDD310D1C38Q36170892-B4B7FBCA-3EEC-4E9F-836B-084E45868D1EQ36960328-67B01CBA-9572-4731-A5D8-269AA3028AE4Q37489709-3236169A-12CC-433E-A2E3-B468696EA434Q37663238-E64DC885-32FE-49F8-8920-6CA19DD02FACQ40060810-0D835183-765D-4835-905D-B95099C4008DQ40130516-985782BB-0B2C-4B33-B7FB-9AE31C31C93AQ40285504-E9DAD739-7BED-47AF-B717-D203995634C2Q40286913-92D02470-CEFE-45AB-8040-0C3C54E3290DQ41129615-BA8D7280-363A-43F2-ABCF-9244A1B5248DQ41813754-EABF31F5-AF44-4B54-9A0D-4F4E3B95D892Q41831644-C4BD9048-DA2E-4562-AF75-9ED026961CCEQ44251070-8557E25A-9C23-4ADF-A34C-9EB010CE3714Q46335989-C438023C-0725-43DE-BDDB-553DB650F0FCQ51009546-9E2429EC-6CF6-4E2F-B206-5CADD42B1D70Q54793529-D174E6B4-1413-4C95-AA92-22047C926192Q58285807-79FDC676-0FDF-4755-8CAA-0F6D5E159F37
P2860
Global antibiotic resistance in Streptococcus pneumoniae.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Global antibiotic resistance in Streptococcus pneumoniae.
@ast
Global antibiotic resistance in Streptococcus pneumoniae.
@en
Global antibiotic resistance in Streptococcus pneumoniae.
@nl
type
label
Global antibiotic resistance in Streptococcus pneumoniae.
@ast
Global antibiotic resistance in Streptococcus pneumoniae.
@en
Global antibiotic resistance in Streptococcus pneumoniae.
@nl
prefLabel
Global antibiotic resistance in Streptococcus pneumoniae.
@ast
Global antibiotic resistance in Streptococcus pneumoniae.
@en
Global antibiotic resistance in Streptococcus pneumoniae.
@nl
P356
P1476
Global antibiotic resistance in Streptococcus pneumoniae.
@en
P2093
Dieter Adam
P356
10.1093/JAC/DKF801
P407
P478
P577
2002-07-01T00:00:00Z